Rocket Pharmaceuticals, Inc.

RCKT· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$2.49+2.05%

2026-11-02

Financials

Valuation Metrics

Rocket Pharmaceuticals, Inc.'s Market Cap is $272M. At end of 2025 it was $390M. Ranked #2930 of 3,118 in US market (top 94%), #1327 of 1,474 on NASDAQ (top 90%), #237 of 265 in Pharmaceuticals, Biotechnology & Life Sciences (top 89%) by Market Cap.

Investment Metrics(as of 2026-11-02)

Metric	Value	Rank
Size
Market Cap	$272M	US#2,930/3,118 Sec#237/265
Revenue	$0.00	US#2,858/3,118 Sec#193/265
Net Income	$-17M	US—/3,118 Sec—/265
Total Assets	$423M	US#2,818/3,118 Sec#177/265
Net Assets	$369M	US#2,413/3,118 Sec#142/265
Value
P/B	0.74x	US#195/3,118 Sec#10/265
EV/EBITDA	9.08x	US#587/3,118 Sec#17/265
FCF Yield	-62.67%	US—/3,118 Sec—/265
Profitability
ROE	-4.68%	US#2,249/3,118 Sec#72/265
ROA	-4.08%	US#2,483/3,118 Sec#82/265
Financial Health
Debt Ratio	14.71%	US#170/3,118 Sec#67/265
Total Debt	$25M	US#2,710/3,118 Sec#179/265
FCF	$-170M	US#2,744/3,118 Sec#196/265
Cash	$225M	US#1,643/3,118 Sec#98/265
Current Ratio	9.24x	US#273/3,118 Sec#82/265
Net Debt/EBITDA	-25.12x	US#12/3,118 Sec#2/265
Performance
1Y Return	-33.95%	US#2,658/3,118 Sec#214/265
1M Return	-2.73%	US#2,316/3,118 Sec#166/265
From 52W High	-54.31%	US#2,740/3,118 Sec#211/265
1Y MDD	-58.87%	US#2,699/3,118 Sec#200/265
Trading
Volume	1,710,709 shares	US#1,180/3,118 Sec#111/265
Trading Value	$4M	US#2,721/3,118 Sec#222/265
Per Share
EPS	$-0.16	US—/3,118 Sec—/265
BPS	$3.38	US#2,436/3,118 Sec#155/265